Treatment effectiveness can have different meanings to patients,” a physician assistant said when discussing therapy for high ...

A poll of experts revealed that few are utilizing talquetamab for patients with pretreated relapsed/refractory myeloma.

Patients with breast cancer who are of childbearing age may face issues that are accentuated by their age, an expert ...

After a patient with estrogen receptor (ER)-positive, HER2-negative metastatic breast cancer experiences disease progression ...

Extensive-stage (stage IV) SCLC, on the other hand, is a disease that has spread outside the bounds of 1 radiation field, and ...

A nurse practitioner discussed considerations for managing aromatase inhibitor-related joint pain in patients with breast ...

As biomarkers continue to be explored in resectable melanoma, oncology nurses will play a crucial role in the clinical trial ...

The FDA granted a priority review to acalabrutinib for the treatment of previously untreated adults with mantle cell lymphoma ...

Oral drugs in the HR-positive, HER2-negative metastatic breast cancer space put a focus on clear patient-provider ...

An expert explained the role oncology nurses and advanced practice providers play in caring for patients with sarcoma during treatment.

Inavolisib plus palbociclib and fulvestrant was approved for the treatment of PIK3CA-mutant, HR-positive, HER2-negative locally advanced or metastatic breast cancer. The FDA approved inavolisib ...

Panelists discuss how axatilimab, a novel therapy for chronic graft-versus-host disease (cGVHD), functions through a unique mechanism of action compared to other treatments, highlighting its potential ...